ORAMED PHARMACEUTICALS INC. (ORMP) Free cash flow 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$9.2MFY2025 · since FY2016: $4.6M → -$9.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.2M | -8.6% |
| FY2024 | -$8.4M | +20.1% |
| FY2023 | -$10.5M | +62.9% |
| FY2022 | -$28.4M | -31.8% |
| FY2021 | -$21.6M | -72.1% |
| FY2020 | -$12.5M | +3.3% |
| FY2019 | -$13.0M | +11.6% |
| FY2018 | -$14.7M | -151.1% |
| FY2017 | -$5.8M | -225.7% |
| FY2016 | $4.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice